3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Non-alcoholic Fatty Liver Disease

3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, P; Dai, J; Jin, H; Yi, J; Yu, X; Zhang, S; Zhang, X	1

Other Studies

1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Non-alcoholic Fatty Liver Disease

Article	Year
Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals. Journal of diabetes investigation, 2019, Volume: 10, Issue:3 Topics: Asian People; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Furans; Humans; Lipids; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prognosis; Propionates	2019

Article

Year

Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.

Journal of diabetes investigation, 2019, Volume: 10, Issue:3

Topics: Asian People; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Furans; Humans; Lipids; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prognosis; Propionates

2019